tiprankstipranks
Trending News
More News >
Ironwood Pharma (IRWD)
NASDAQ:IRWD

Ironwood Pharma (IRWD) Stock Statistics & Valuation Metrics

Compare
310 Followers

Total Valuation

Ironwood Pharma has a market cap or net worth of $98.48M. The enterprise value is ―.
Market Cap$98.48M
Enterprise Value

Share Statistics

Ironwood Pharma has 161,819,850 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding161,819,850
Owned by Insiders13.05%
Owned by Institutions35.88%

Financial Efficiency

Ironwood Pharma’s return on equity (ROE) is 2.89 and return on invested capital (ROIC) is -258.69%.
Return on Equity (ROE)2.89
Return on Assets (ROA)-2.13
Return on Invested Capital (ROIC)-258.69%
Return on Capital Employed (ROCE)-4.85
Revenue Per Employee1.75M
Profits Per Employee-3.96M
Employee Count253
Asset Turnover0.94
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Ironwood Pharma is -1.77. Ironwood Pharma’s PEG ratio is <0.01.
PE Ratio-1.77
PS Ratio0.00
PB Ratio-0.75
Price to Fair Value-5.13
Price to FCF1.90
Price to Operating Cash Flow1.89
PEG Ratio<0.01

Income Statement

In the last 12 months, Ironwood Pharma had revenue of 442.74M and earned -1.00B in profits. Earnings per share was -6.45.
Revenue442.74M
Gross Profit337.95M
Operating Income-945.43M
Pretax Income-948.07M
Net Income-1.00B
EBITDA-924.86M
Earnings Per Share (EPS)-6.45

Cash Flow

In the last 12 months, operating cash flow was 124.17M and capital expenditures -353.00K, giving a free cash flow of 123.82M billion.
Operating Cash Flow124.17M
Free Cash Flow123.82M
Free Cash Flow per Share0.77

Dividends & Yields

Ironwood Pharma pays an annual dividend of $2.285, resulting in a dividend yield of ―
Dividend Per Share$2.285
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.50
52-Week Price Change-90.67%
50-Day Moving Average0.85
200-Day Moving Average2.86
Relative Strength Index (RSI)40.85
Average Volume (3m)2.65M

Important Dates

Ironwood Pharma upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateApr 02, 2019

Financial Position

Ironwood Pharma as a current ratio of 0.84, with Debt / Equity ratio of -197.50%
Current Ratio0.84
Quick Ratio0.84
Debt to Market Cap0.39
Net Debt to EBITDA-0.67
Interest Coverage Ratio-43.71

Taxes

In the past 12 months, Ironwood Pharma has paid 83.49M in taxes.
Income Tax83.49M
Effective Tax Rate-0.09

Enterprise Valuation

Ironwood Pharma EV to EBITDA ratio is -2.60, with an EV/FCF ratio of 13.11.
EV to Sales5.42
EV to EBITDA-2.60
EV to Free Cash Flow13.11
EV to Operating Cash Flow13.09

Balance Sheet

Ironwood Pharma has $88.21M in cash and marketable securities with $614.87M in debt, giving a net cash position of $526.66M billion.
Cash & Marketable Securities$88.21M
Total Debt$614.87M
Net Cash$526.66M
Net Cash Per Share$3.25
Tangible Book Value Per Share-$2.25

Margins

Gross margin is 99.71%, with operating margin of -213.54%, and net profit margin of -226.37%.
Gross Margin99.71%
Operating Margin-213.54%
Pretax Margin-214.14%
Net Profit Margin-226.37%
EBITDA Margin-208.90%
EBIT Margin-209.25%

Analyst Forecast

The average price target for Ironwood Pharma is $0.85, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$0.85
Price Target Upside39.34% Upside
Analyst ConsensusHold
Analyst Count6
Revenue Growth Forecast-23.18%
EPS Growth Forecast97.12%

Scores

Smart Score3
AI Score39
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis